Cambridge Investment Research Advisors’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-6,203
| Closed | -$469K | – | 4099 |
|
|
2026
Q1 | $469K | Sell |
6,203
-1,009
| -14% | -$75.9K | ﹤0.01% | 2861 |
|
|
2025
Q4 | $537K | Sell |
7,212
-22,699
| -76% | -$1.66M | ﹤0.01% | 2650 |
|
|
2025
Q3 | $2.02M | Sell |
29,911
-1,811
| -6% | -$120K | 0.01% | 1502 |
|
|
2025
Q2 | $2.07M | Sell |
31,722
-334
| -1% | -$20K | 0.01% | 1414 |
|
|
2025
Q1 | $1.98M | Buy |
32,056
+528
| +2% | +$35K | 0.01% | 1356 |
|
|
2024
Q4 | $2.27M | Buy |
31,528
+1,246
| +4% | +$97.3K | 0.01% | 1277 |
|
|
2024
Q3 | $2.47M | Sell |
30,282
-118
| -0.4% | -$9.44K | 0.01% | 1193 |
|
|
2024
Q2 | $2.26M | Sell |
30,400
-712
| -2% | -$53.4K | 0.01% | 1212 |
|
|
2024
Q1 | $2.42M | Buy |
31,112
+192
| +0.6% | +$14.3K | 0.01% | 1145 |
|
|
2023
Q4 | $2.21M | Sell |
30,920
-668
| -2% | -$46.5K | 0.01% | 1133 |
|
|
2023
Q3 | $2.19M | Sell |
31,588
-2,122
| -6% | -$160K | 0.01% | 1074 |
|
|
2023
Q2 | $2.73M | Buy |
33,710
+2,270
| +7% | +$186K | 0.01% | 989 |
|
|
2023
Q1 | $2.54M | Sell |
31,440
-1,976
| -6% | -$159K | 0.01% | 999 |
|
|
2022
Q4 | $2.5M | Sell |
33,416
-6,845
| -17% | -$487K | 0.01% | 961 |
|
|
2022
Q3 | $2.6M | Sell |
40,261
-41,265
| -51% | -$2.86M | 0.01% | 905 |
|
|
2022
Q2 | $5.65M | Buy |
81,526
+45,239
| +125% | +$3.36M | 0.03% | 539 |
|
|
2022
Q1 | $2.79M | Buy |
36,287
+6,373
| +21% | +$458K | 0.01% | 956 |
|
|
2021
Q4 | $2.29M | Buy |
29,914
+2,815
| +10% | +$207K | 0.01% | 1062 |
|
|
2021
Q3 | $2M | Buy |
27,099
+17,805
| +192% | +$1.34M | 0.01% | 1100 |
|
|
2021
Q2 | $620K | Sell |
9,294
-2,297
| -20% | -$154K | ﹤0.01% | 1885 |
|
|
2021
Q1 | $862K | Buy |
11,591
+1,662
| +17% | +$126K | ﹤0.01% | 1533 |
|
|
2020
Q4 | $723K | Buy |
9,929
+2,931
| +42% | +$207K | ﹤0.01% | 1520 |
|
|
2020
Q3 | $465K | Buy |
6,998
+1,630
| +30% | +$103K | ﹤0.01% | 1648 |
|
|
2020
Q2 | $306K | Sell |
5,368
-516
| -9% | -$25.3K | ﹤0.01% | 1868 |
|
|
2020
Q1 | $207K | Buy |
5,884
+1,501
| +34% | +$71.5K | ﹤0.01% | 1910 |
|
|
2019
Q4 | $229K | Buy |
+4,383
| New | +$218K | ﹤0.01% | 2110 |
|
|
2018
Q1 | – | Sell |
-5,493
| Closed | -$235K | – | 2187 |
|
|
2017
Q4 | $235K | Buy |
+5,493
| New | +$219K | ﹤0.01% | 1817 |
|
|
2017
Q3 | – | Sell |
-4,700
| Closed | -$213K | – | 2029 |
|
|
2017
Q2 | $213K | Buy |
+4,700
| New | +$207K | ﹤0.01% | 1715 |
|
Other funds holding HOLX
Cambridge Investment Research Advisors's HOLX Position: Q2 2026 in Review
Cambridge Investment Research Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 6,203 shares — an estimated $469K sold.
Cambridge Investment Research Advisors first reported a position in HOLX in Q2 2017 and held it in 28 quarters. The position peaked at $5.65M in Q2 2022. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Cambridge Investment Research Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 6,203 Hologic shares in Q2 2026, an estimated $469K.
- Cambridge Investment Research Advisors first reported a position in Hologic in Q2 2017 and held it in 28 quarters.
- Cambridge Investment Research Advisors's Hologic position peaked at $5.65M in Q2 2022.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.